Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NPHC
From my experience nearly all the biggest runners ive been in went through craziest dips and shakes bombarded by nothing but hate. Then one day company turns things around and it runs 1000%
If i am a millionaire looking to JV with NPHC and im looking at the products and assets of the company the market it services and the orders/connections it has.
If NPHC truly has worked its way into the GSA and VA all thats needed is nfunding to launch the company into big profits.
If the only problem now is the MANAGMENT from the CEO and his actions then I would assess how to deal with it. Which is to prove these allegations are false or replace the CEO with a new chairman and Rik could still remain majority shareholder
Overall this does not stop business from occuring. Tesla didnt stop producing cars just because musk got sued by the SEC.
This is what people are missing and this is why im holding
Mav
Wrong
All Rik needs to do is.
1. Close the JV partner ship funding. Take the money. Market and manufacter product
2. Get back on the GSA and begin announcing orders to various branches of the government.
The price will go up so high so hard and so fast...
every flipp3r who have been holding us back will get smashed to bits. Only to Come back with sellers remorse crying and telling us how much they hate Rik blah blah blah blah.
Often these doomsday dips come right before the EPIC rip that nobody seen coming and leaves all the sideliners running.
Time will tell.
NPHC
Mav
Exactly.
Just because of the lawsuit...
the products,the IP the patents, the networking into VA, the connections set up with military dont become worth nothing. There is a long list of intellectual and tangible assets that deem the companys worth to be far beyond the pps today
Anyone here want to honestly factually show me how all of the above is only worth 1 mil market cap.
Rik could quit today and sell the company for exponentially more than the market cap today.
The claims made in the suit have will be disputed and NPHC will continue on with business as planned. Says that right in the 8k.
People want to try and act like its all over but its not.
Mav
NPHC
Everyone looking for someone to blame. I supported this company because of its products and IP have huge disruptive potential in a market that has been corrupted and monopolized by pharmaceutical companies
I believe in the product because it works. I post valid information here to share the facts and evidence i found to support my belief in the company
I have never bounced back n forth based on my daily share count. And i havent posted here a 100 times a day everyday.
I manage TWO business, i have 4 young kids, a wife, and i am a real man with real struggles as anyone else. I have been working 12 to 18hrs a day for months im not a f@#kin promoter. Anyone can say anything behind a keyboard yet there is many here who know me face to face.
I am invested here. Im not selling and thats my choice. Im well diversified across a wide range of markets of both stock and real assets. I can afford the loss. And every OTC play comes with the risk of losing it all. Or gaining beyond your wildest dreams
Ive done both. Anyone who claims to have only won all of the time is lying. Each of us hits the buy or sell button all on our own and there is nobody to blame but yourself if your not succeeding in the market or in life.
This is not over. If it was over this would have beem halted. We will see how it unfolds.
Mav
NPHC
Being charged by claims is entirely different then convicted with evidence
We will see what actually happens in the near future. Imo
Mav
NPHC.
Im still in.
Im at work running a machine and managing 4 guys. Cant really dive into this yet
The SEC claims Rik doesnt farm snake venom and doesnt sell a product.... so i guess the NYLOXIN in my cubbord is figment of my imagination
I think this is BS claim by SEC
IMHO
Mav
NPHC - the news today is just the beginning
RBIZ- Huge news.
Glad i LOADED the BOAT!!!!
Been quietly waitjng for the market cap correction coming here soon imo
Mav
DSGT - added here
RSHN adding and holding for .01+
IMHO October will be amazing
Mav
RSHN- Must read post.
This is why i went long on RSHN
I have...
Been in a few that held their exponential gains. Not many actually do.
Only the real deal companies that move up based on strong FUNDEMENTALS and excecution from MANAGMENT
I believe DSGT is going to follow suit.
Mav
most important thing to remember....
When a stock is running and you begin taking profits:
1. Put your sell orders in SMALL LOTS.
2. Spread them out over a price range.
3. Be patient and wait for them to be bought.
4. DO NOT sell into the bid with huge sell blocks.
I cannot tell you how many times ive seen people taking profits the wrong way and kill or drastically slow down a run.
And they loose out in the end because it keeps going and they get left behind.
Stocks run harder faster and higher when the longs sell properly. It is really simple yet such a major effect on the overall performance of a rally.
If your new and do not understand what we are talking about in these posts then you need to get educated asap.
If your a flipp3r and think your going to stop a major run with a big ask wall then you have yet to experience a major run.
Ive been there many times and had people brag to my face about a ten baggerfrom .001 to .01. I stayed patient slowly selling Only to watch it keep going to .10.
Mav
DSGT - legitimately UNDERVALUED
Its all in the DD and fundementals.
Its as simple as that.
How high will it go, when it will go there.... is all speculation.
MAJOR players are here because the potential is real
Mav
Watch how fast it moves when catalysts hit
Mark it
DSGT...
If people seen their account jump up and down by the amount mine does with DSGT they would probably sh%# themselves
Patience is not the ability to wait. It is how you act while waiting
Patiently waiting for the inevitable market cap correction coming here imo
Mav
NPHC
Nearly all the exact same negative aspects about Rik were pounded on the table last year when we were at .0006.
Then catalysts hit and we hit .007.
The products are real
The products work
The products have huge opportunity to enter the opioid alternative pain relief .arket which is measured in the billions.
JV partnership funding is not a simple process to negotiate and establish. Some are trying to capitalize on the delays and accumulate cheaps shares before the explosion.
If i didnt have shares and if i didnt believe i would not be here. Thats me. I play the game knowing the risks and i never BS my way to get cheapies. Each to their own
Mav
DSGT - Great news
Retail and MMs playing games trying to hold this gem down before the imminent explosion upwards
Mav
NPHC - excellent post. Must read.
We are in a good situation.
We are entering 4th quarter with end summer return of volume. The OTC harvest as they call it
This JV is been years in the making and its potential is unprecedented
Beware of the false information that circulates around the markets. Do your DD and if you dig into the assets of this company you will see just how HUUUUUGE of a opportunity these prices are.
Big things are on horizon for NPHC IMHO
Mav
Great post.
This is true. And what people need to realize is that NPHC is extremely UNDERVALUED here.
Alot of big catalysts pending.
Confirmation of JV
Listing on GSA
Confirmation product orders
All of which send us on PARABOLIC breakout with gains of 100%++ imo. Seen it happen before and many missed it and were mad they didnt buy the fear during the calm before the storm.
BUYING OPPORTUNITY here imo
Mav
DSGT- Excellent must read post.
Lets all remember:
MOST COMPANIES WITH ORPHAN DRUG STATUS HAVE MARKET CAPS IN THE HUNDREDS OF MILLIONS!
OWC*P RAN TO 300 MILLION MARKET CAP JUST ON THE RUMOR OF GETTING ORPHAN DRUG STATUS! NPHC HAS IT and is at 2.18 MC!!!
Mav
NPHC - ORPHAN DRUG STATUS DESIGNATION
In September of 2015 NPHC was granted Orphan Designation by the US-FDA for the treatment of Pediatric Multiple Sclerosis. We are currently working with potential sites of care to conduct a Phase I/II in Pediatric MS. The designation of RPI-78M as an Orphan Drug provides Nutra Pharma with a 7-year period of market exclusivity in the U.S. once the drug is approved. Additional benefits over conventional drug applications include: tax credits for clinical research costs, the ability to apply for grant funding, clinical trial design assistance, plus assistance from the FDA in the drug development process and the waiver of Prescription Drug User Fee Act (PDUFA) filing fees which could be in excess of $2.5 million. The granting of Orphan Drug Designation allows the Company to move forward with their preparation of an Investigative New Drug Application and proposal of clinical trials. The FDA grants Orphan Drug Designation status to products that treat rare diseases, providing incentives to sponsors developing drugs or biologics. According to the FDA, the Orphan Drug program has successfully enabled the development and marketing of more than 400 drugs and biologic products for rare diseases since 1983. Evaluate Ltd., in its 2014 EvaluatePharma Orphan Drug Report, estimated that orphan drug sales will constitute 19% of the total share of prescription drug sales by 2020, totaling $176 BILLION.
Profitability and Market Value of Orphan Drug Companies: A Retrospective, Propensity-Matched Case-Control Study
Link to the article:
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0164681
"We conducted a retrospective, propensity score matched study of publicly-listed orphan companies. Cases were defined as holders of orphan drug market authorisation in Europe or the USA between 2000–12. Control companies were selected based on their propensity for being orphan drug market authorisation holders. We applied system General Method of Moments to test whether companies with orphan drug market authorization are valued higher, as measured by the Tobin’s Q and market to book value ratios, and are more profitable based on return on assets, than non-orphan drug companies."
Publicly listed pharmaceutical companies that are orphan drug market authorization holders are associated with higher market value and greater profits than companies not producing treatments for rare diseases.
SUMMARY: HAVING ORPHAN DRUG STATUS IS A BIG DEAL!!
Multiple Sclerosis (MS)
Multiple Sclerosis (MS) is thought to be an autoimmune disease that primarily causes central nervous system problems. In MS, the insulating fatty material surrounding the nerve fibers, also known as myelin, which functions to speed signaling from one end of the nerve cell to the other, is attacked by cells of the immune system causing problems in signal transduction. MS is the most common of demyelinating disorders, having a prevalence of approximately 1 per 1,000 persons in most of the United States and Europe. According to the Accelerated Cure Project for Multiple Sclerosis, a national nonprofit organization, 400,000 people in the US are affected by MS and another 2.1 million globally, with 10,000 new cases diagnosed in the US every year. According to the National Multiple Sclerosis Society, although MS occurs most commonly in adults, it is also diagnosed in children and adolescents. Estimates suggest that 8,000-10,000 children (up to 18 years old) in the United States have MS, and another 10,000-15,000 have experienced at least one symptom suggestive of MS. Studies suggest that two to five percent of all people with MS have a history of symptom onset before age 18.
RPI-78M has been utilized in two clinical studies, which were completed at the Charles Dent Metabolic Unit located in London, England. The last trial was classified as a Phase IIb/IIIa study. These studies provided important safety data, showing RPI-78M to be well tolerated by the patients. Further study is warranted to provide data on the potential efficacy of RPI-78M to treat the symptoms of AMN.
RPI-78M has shown efficacy in animal models (EAE) for MS and ReceptoPharm is planning new animal studies to gain more insight into the levels of protection that the drugs afford. In one study conducted in August 2007, all members of an untreated animal control group developed signs of disease with different levels of paralysis/muscle weakness. A similar group in the August 2007 study treated with RPI-78M showed no disease in 90% of the animals in both acute and chronic applications of the test. Moreover, there were no toxicities reported though the animals which received doses the equivalent of 280 times a human dose.
* MS 15-18 billion dollar per year market
* No descent drugs for treatment of MS. They Shut off immune system
* Modulates the immune system.
* 300 patients trialed - disease progression stops and symptoms improve. AMAZING
* FDA Trials Phase II coming
* Addresses multiple health conditions
http://www.receptopharm.com/drug_development/
* RPI-78M is being developed for the treatment of Multiple Sclerosis (MS) and Adrenomyeloneuropathy AMN).Other neurological disorders that may be served by RPI-78M include Myasthenia Gravis (MG) and Amyotrophic Lateral Sclerosis (ALS)
* Collaboration: University of Maryland,production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple Sclerosis
https://finance.yahoo.com/news/nutra-pharma-announces-collaboration-university-123000318.html
It feels good Knowing that I am invested into a company that is actively seeking to create a revolutionary new drug that could help thousands of children with MS... Yet another reason I am invested in NPHC.
MARKET VALUES OF MS
MS affects an estimated 2.5 million people globally with approximately 400,000 sufferers in the United States. There are 12 approved drugs for the treatment of this disease. According to an April 2015 article published in the journal Neurology , the average annual cost of these drugs has increased to over $60,000 per person. In 2013, sales by one manufacturer, Teva, were reported to be $4.328 billion for its drug, Copaxone. Biogen has the largest market share in the MS drug category; bringing in $8 billion from the sales of Avonex, Tysabri and Tecfidera. The global multiple sclerosis therapeutics market is expected to reach USD 24.8 billion by 2024 according to a May, 2016 report by Grand View Research, Inc.
MS MARKET VALUE CURRENTLY 8 BILLION AND EXPECTED TO REACH 24.8 BILLION BY 2024!!!!!
NPHC deserves a market cap FAR HIGHER than what we have today!!
Mav
NPHC current market cap : 2.18 million
explain to me how that is overvalued. not just IMO... I want FACTS
the SHELL alone is worth 20M+
A company could buy the shell for 20M and have debt carry forward write offs that total more than 20M. yes that means they would actually come out on TOP after the tax savings.
The shell alone is worth a minimum 20M and even with the OS completely maxed at 8 billion shares that represents a pps of .0025. FOR THE SHELL
Now lets talk about the IP and the products. The products in NPHC's portfolio are extremely valuable. Orphan Drug status, Opioid Alternative pain management, counter measures to nerve gas, all Worth far more than 2.18 million market cap
Market cap is one of thee most important aspects to focus on whenever I make investment decisions. NPHC remains extremely undervalued and I challenge anyone to actually prove otherwise
Mav
RBIZ - EXTREMELY UNDERVALUED here
Loading the boat in this range and holding for copper and silver above. Its coming soon imo
Mav
SSOF - holding long term here
I dont post much cuz im busy yet ive been accumulating all summer. One of my good friends informed me of this stock and the last one i trusted him on went from .02 to .50...
Im patiently wating
Mav
RSHN - BLOCKBUSTER MJ play in the making
Been quietly accumulating herr through the summer.
My friends and i are holding a nice size positions now for the long term. Not missing out on the next POT*
This could be HUGE imo!!
Mav
NPHC....
Who here has 30k sitting around collecting dust...?
What average American throws 30k into a stock at .0006...?
Anyone with 30k cash to spend into triple zero stock is definitely not a newbie...
It is definitely someone who is got big money and people with money make informed decisions.
We have 30k dollars on the bid with one MM another 30k between a few others.
This accumulation is effectively been going on since march. Ive seen Institutional MMs and HUGE bids absorbing dilution and any sellers. So the OS is increased yet the float is being methodically bought up at the same time
And dont try and tell me its ihubb3rs following DD that are throwing 30k bids up right now and for the past few months. Well.over a million dollars is been spent.
IMHO the JV partners are buying up the float and they got rik on their puppet strings as they squeeze every last long out and absorb the toxic notes. Until they are ready
They drop a few catalysts and kaboom the stock will instantly skyrocket and never look back. Ensuring a profitable return on their investment both through the stock and the profit share deal with Rik.
All IMHO
This is why im WAITING for further confirmations.
Mav
Good morning DSGT
Patience will pay off here. IMHO it is going to shock alot of people.
Thats why myself and many i know have fully loaded the boat down here.
Mav
NPHC OS....
Even at this OS the market cap at .007 is 24.5 million
The shell is worth more than that. Debt carry forwards alone are almost double that.
So a company could buy NPHC shell for 24.5 mill and save around 20 mill in taxes the next year.
NPHC is UNDERVALUED
Mav
NPHC - it is simple
Buy n hold
Sell and move on
Anything else is suspicious activity imho
We all know how the game works.
EOM
Mav
NPHC.
Been here before at .0007 everyone hated Rik
Then it ran to .007 and everybody loved Rik.
Now its back to hating Rik... when it runs the bears will hide yet again and return on cue...
Nice to see so many Still watching and following the stock after all this while... lol
Time will tell what unfolds
For me it is a long term hold.
Mav
NPHC
Yesterday was jewish holiday
I think we see updates next week.
Just in time for the buying volume to come back after a long grueling summer of total manipulation... just about every ticker is been hammered down all summer and loaded up on
Watch for the parabolic run to come imo
Mav
NPHC - still waiting...
For u to answer my questions ive been asking for over a year.
1. Show me another biotech with comparable IP and real products that has the same market cap.
Crickets.
2. Explain to me why anyone would incessantly follow a stock that they dont believe in...? We are all here for some kind of gain? Whats to gain if u dont believe?? ($horting 101)
Crickets again. ( followed by quick removal. )
LOL
NPHC
Patiently waiting
Mav
NPHC - 93 million bidding at .0006
And they try and tell us nobody cares or wants to buy this stock... lol
That is the short cover right there and the reason for the months of manipulation imo
Mav
DSGT - i agree on all points.
We are simply coming up out of the gutter and churning through the one tick flipp3rs and MM naked short sellers.
All in time. DSGT will explode to pennies without warning imo
I will be there when it does
Mav
RSHN - blockbuster MJ play of 2018
Mark.it.
Mav
DSGT - Typical games before the gains.
Yaaaaawn...
Anyone who got shook today needs to give their head a shake. Company is minimum 10x UNDERVALUED from here and thats just the beginning.
A new season is upon us and volume will return. These low volume games no longer have the ability to hold a gem.like this down
Come back and see where we are at in 2 months. IMHO we will be 10x higher minimum.
Mark it
Mav
RBIZ- extremely UNDERVALUED here
We have a rock solid base here at .005 ready for our march back to .01++
Mav
RSHN - my MJ long term hold
Building new base for launch into pennies imo
Big things are coming.
Mav